MTS Medication Technologies Switches to The NASDAQ Stock Market
July 02 2008 - 12:27PM
Business Wire
MTS Medication Technologies, Inc. (�MTS�) (AMEX:MPP) announced
today that its Board of Directors has approved the decision to
switch the listing of its common stock from The American Stock
Exchange to The NASDAQ Stock Market LLC�. On July 2, 2008, MTS
provided The American Stock Exchange the required written notice of
MTS' intention to withdraw the listing of its common stock from The
American Stock Exchange. Effective July 15, 2008, MTS will trade on
The NASDAQ Capital Market under the new symbol (NASDAQ:MTSI). MTS's
common stock will continue to trade on The American Stock Exchange
under its current symbol MPP until such date. �This decision was
reached after careful consideration of capital market alternatives
and analysis of the electronic market model, which provides added
visibility to our investors,� said Todd E. Siegel, Chairman and
Chief Executive Officer of MTS. �We believe that NASDAQ�s
electronic multiple market maker structure will provide our company
with enhanced exposure and liquidity, while at the same time
providing investors with the best prices, the fastest execution and
the lowest cost per trade. As the world�s largest electronic stock
market, NASDAQ promotes innovation and attracts leading growth
companies from a diverse group of sectors. We are proud to be a
part of The NASDAQ Stock Market.� About MTS Founded in 1984, MTS
Medication Technologies (www.mts-mt.com) is an international
provider of medication compliance packaging systems designed to
improve medication dispensing and administration. MTS manufactures
automated packaging machines and related consumables for
prescription medications and nutritional supplements. The Company
serves more than 8,000 pharmacies worldwide. About NASDAQ� NASDAQ
is the largest U.S. electronic stock market. With approximately
3,200 companies, it lists more companies and, on average, its
systems trade more shares per day than any other U.S. market.
NASDAQ is home to companies that are leaders across all areas of
business including technology, retail, communications, financial
services, transportation, media and biotechnology. NASDAQ is the
primary market for trading NASDAQ-listed stocks. For more
information, visit NASDAQ Web site at www.nasdaq.com or at
www.nasdaq.com/newsroom. This news release contains forward-looking
statements within the meaning of the Private Securities Litigation
Reform Act of 1995. Such statements include the anticipated timing
of the trading of MTS' common stock on The NASDAQ Capital Market,
the effect of such listing on MTS, its common stock and investors,
and the expectation of an orderly transfer to NASDAQ from The
American Stock Exchange. Forward-looking statements are based on
current expectations and assumptions, and entail various risks and
uncertainties that could cause actual results to differ materially
from those expressed in such forward-looking statements. Important
factors known to MTS that could cause actual results to differ
materially from those expressed in such forward-looking statements
include the ability of MTS to continue to satisfy initial listing
requirements of The NASDAQ Capital Market and other factors
identified and discussed from time to time in MTS' filings with the
Securities and Exchange Commission, including those factors
discussed in MTS' most recent annual report on Form 10-K and
subsequent quarterly reports on Form 10-Q, which discussions also
are incorporated herein by reference. All forward-looking
statements speak only as of the date of this release. MTS
undertakes no obligation to update or revise any forward-looking
statement, whether as a result of new information, future events or
otherwise.
Mts Medications (AMEX:MPP)
Historical Stock Chart
From Sep 2024 to Oct 2024
Mts Medications (AMEX:MPP)
Historical Stock Chart
From Oct 2023 to Oct 2024